Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review

doi:10.1016/j.jacc.2020.03.060

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review

Research output: Contribution to journal › Review article › peer-review

305 Scopus citations

Abstract

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.

Original language	English
Pages (from-to)	2602-2618
Number of pages	17
Journal	Journal of the American College of Cardiology
Volume	75
Issue number	20
DOIs	https://doi.org/10.1016/j.jacc.2020.03.060
State	Published - May 26 2020

Bibliographical note

Publisher Copyright:
© 2020 American College of Cardiology Foundation

Funding

Dr. Cho has received research support from Novartis; has received research support from and served as a consultant to Esperion and Amgen; and has served as a consultant to AstraZeneca. Dr. Minissian has served as a consultant for Amgen, Medtelligence, and the North American Center for Continuing Medical Education; and has received research support from the National Institutes of Health and NIHF. Dr. Pepine has received support from the NIH/NHLBI (WISE HFpEF, HL146158), NIH/NCATS (University of Florida Clinical and Translational Science, UL1TR001427), the Gatorade Trust through the University of Florida Department of Medicine, the McJunkin Family Foundation, and the U.S. Department of Defense (WARRIOR, PR161603). Dr. Vogelman has served as a consultant for the American Heart Association; and has served as a speaker for Aptus Health. All other authors have reported that they have no relationships relevant to the contents of this paper.

Funders	Funder number
Gatorade Trust
McJunkin Family Foundation
NIHF
North American Center for Continuing Medical Education
Clinical and Translational Science Institute, University of Florida
University of Florida Department of Medicine
Warrior Human Performance Laboratory	PR161603
National Institutes of Health (NIH)
U.S. Department of Defense
National Heart, Lung, and Blood Institute (NHLBI)	HL146158
National Center for Advancing Translational Sciences (NCATS)	UL1TR001427

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

adverse pregnancy outcomes
aspirin
atrial fibrillation
cardiovascular disease
gestational diabetes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2020.03.060

Cite this

@article{caafc54c821c41439d3bc754373b8d92,

title = "Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review",

abstract = "Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.",

keywords = "adverse pregnancy outcomes, aspirin, atrial fibrillation, cardiovascular disease, gestational diabetes",

author = "Leslie Cho and Melinda Davis and Islam Elgendy and Kelly Epps and Lindley, \{Kathryn J.\} and Mehta, \{Puja K.\} and Michos, \{Erin D.\} and Margo Minissian and Carl Pepine and Viola Vaccarino and Volgman, \{Annabelle Santos\}",

note = "Publisher Copyright: {\textcopyright} 2020 American College of Cardiology Foundation",

year = "2020",

month = may,

day = "26",

doi = "10.1016/j.jacc.2020.03.060",

language = "English",

volume = "75",

pages = "2602--2618",

number = "20",

}

TY - JOUR

T1 - Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women

T2 - JACC State-of-the-Art Review

AU - Cho, Leslie

AU - Davis, Melinda

AU - Elgendy, Islam

AU - Epps, Kelly

AU - Lindley, Kathryn J.

AU - Mehta, Puja K.

AU - Michos, Erin D.

AU - Minissian, Margo

AU - Pepine, Carl

AU - Vaccarino, Viola

AU - Volgman, Annabelle Santos

PY - 2020/5/26

Y1 - 2020/5/26

N2 - Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.

AB - Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.

KW - adverse pregnancy outcomes

KW - aspirin

KW - atrial fibrillation

KW - cardiovascular disease

KW - gestational diabetes

UR - https://www.scopus.com/pages/publications/85084392330

UR - https://www.scopus.com/pages/publications/85084392330#tab=citedBy

U2 - 10.1016/j.jacc.2020.03.060

DO - 10.1016/j.jacc.2020.03.060

M3 - Review article

C2 - 32439010

AN - SCOPUS:85084392330

SN - 0735-1097

VL - 75

SP - 2602

EP - 2618

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 20

ER -

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review

Abstract

Bibliographical note

Funding

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this